1. Home
  2. SPRC vs APTO Comparison

SPRC vs APTO Comparison

Compare SPRC & APTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPRC
  • APTO
  • Stock Information
  • Founded
  • SPRC 2004
  • APTO 1986
  • Country
  • SPRC Israel
  • APTO Canada
  • Employees
  • SPRC N/A
  • APTO N/A
  • Industry
  • SPRC Biotechnology: Pharmaceutical Preparations
  • APTO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • SPRC Health Care
  • APTO Health Care
  • Exchange
  • SPRC Nasdaq
  • APTO Nasdaq
  • Market Cap
  • SPRC 11.6M
  • APTO 13.2M
  • IPO Year
  • SPRC N/A
  • APTO N/A
  • Fundamental
  • Price
  • SPRC $0.60
  • APTO $0.21
  • Analyst Decision
  • SPRC
  • APTO Strong Buy
  • Analyst Count
  • SPRC 0
  • APTO 3
  • Target Price
  • SPRC N/A
  • APTO $4.33
  • AVG Volume (30 Days)
  • SPRC 24.5M
  • APTO 19.3M
  • Earning Date
  • SPRC 02-15-2025
  • APTO 11-08-2024
  • Dividend Yield
  • SPRC N/A
  • APTO N/A
  • EPS Growth
  • SPRC N/A
  • APTO N/A
  • EPS
  • SPRC N/A
  • APTO N/A
  • Revenue
  • SPRC $1,747,000.00
  • APTO N/A
  • Revenue This Year
  • SPRC N/A
  • APTO N/A
  • Revenue Next Year
  • SPRC N/A
  • APTO N/A
  • P/E Ratio
  • SPRC N/A
  • APTO N/A
  • Revenue Growth
  • SPRC N/A
  • APTO N/A
  • 52 Week Low
  • SPRC $0.20
  • APTO $0.13
  • 52 Week High
  • SPRC $6.78
  • APTO $2.30
  • Technical
  • Relative Strength Index (RSI)
  • SPRC 52.60
  • APTO 45.54
  • Support Level
  • SPRC $0.63
  • APTO $0.21
  • Resistance Level
  • SPRC $0.91
  • APTO $0.25
  • Average True Range (ATR)
  • SPRC 0.22
  • APTO 0.02
  • MACD
  • SPRC -0.00
  • APTO 0.00
  • Stochastic Oscillator
  • SPRC 16.95
  • APTO 19.86

About SPRC SciSparc Ltd.

SciSparc Ltd is a specialty clinical-stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.

About APTO Aptose Biosciences Inc.

Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology. The Company's small molecule cancer therapeutics pipeline includes products designed to provide single agent efficacy and to enhance the efficacy of other anti-cancer therapies and regimens without overlapping toxicities.

Share on Social Networks: